Ann Apolloni

发表

Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase*

J. Hancock, S. Roy, J. Yan, 1998, The Journal of Biological Chemistry.

Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.

Ann Apolloni, T. Sculley, 1994, Virology.

Arginine Methylation Increases the Stability of Human Immunodeficiency Virus Type 1 Tat

D. Harrich, Ann Apolloni, D. Jans, 2009, Journal of Virology.

A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.

D. Harrich, Ann Apolloni, M. Kershaw, 2013, Human gene therapy.

Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors

D. Harrich, C. Abbott, Ann Apolloni, 2012, Proceedings of the National Academy of Sciences.

Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains

J. Hancock, A. Harding, R. Parton, 1999, Nature Cell Biology.

Characterization of RasGRP2, a Plasma Membrane-targeted, Dual Specificity Ras/Rap Exchange Factor*

N. Hayward, S. Grimmond, J. Hancock, 2000, The Journal of Biological Chemistry.

Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis

S. Burrows, R. Khanna, D. Moss, 2004, Springer Seminars in Immunopathology.

associated non-Hodgkin lymphoma Subtypes of Epstein-Barr virus in human immunodeficiency virus-

D. Cooper, Ann Apolloni, J. Turner, 2011 .

Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein‐Barr virus

S. Burrows, D. Moss, A. Suhrbier, 1992, European journal of immunology.

H-ras but Not K-ras Traffics to the Plasma Membrane through the Exocytic Pathway

J. Hancock, M. Lindsay, I. Prior, 2000, Molecular and Cellular Biology.

14-3-3 Facilitates Ras-Dependent Raf-1 Activation In Vitro and In Vivo

R. McPherson, J. Hancock, S. Roy, 1998, Molecular and Cellular Biology.

Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6

D. Harrich, Ann Apolloni, Ting Wei, 2013, Virology Journal.

Human Immunodeficiency Virus Type 1 Protease Regulation of Tat Activity Is Essential for Efficient Reverse Transcription and Replication

D. Harrich, Ann Apolloni, J. Mak, 2003, Journal of Virology.

and David Transcription and Replication Essential for Efficient Reverse Protease Regulation of Tat Activity Is Human Immunodeficiency Virus Type

D. Harrich, Ann Apolloni, J. Mak, 2003 .

Human immunodeficiency virus type 1 reverse transcription is stimulated by tat from other lentiviruses.

D. Harrich, Ann Apolloni, J. Scott, 2002, Virology.

Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.

D. Cooper, D. Moss, Ann Apolloni, 1990, The Journal of infectious diseases.

Nullbasic, a Potent Anti-HIV Tat Mutant, Induces CRM1-Dependent Disruption of HIV Rev Trafficking

D. Harrich, Ann Apolloni, D. Jans, 2012, PloS one.

Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.

D. Cooper, D. Moss, Ann Apolloni, 1989, Virology.

Protein methylation is required to maintain optimal HIV-1 infectivity

David Warrilow, D. Harrich, Ann Apolloni, 2006, Retrovirology.

The HIV-1 Tat protein stimulates reverse transcription in vitro.

D. Harrich, A. Suhrbier, Ann Apolloni, 2007, Current HIV research.

A Mutant Tat Protein Inhibits HIV-1 Reverse Transcription by Targeting the Reverse Transcription Complex

D. Harrich, Ann Apolloni, Sally Martin, 2015, Journal of Virology.

HIV-1 Tat implicated as a key factor in viral spread

D. Harrich, Ann Apolloni, D. Warrilow, 2008 .

Will diverse Tat interactions lead to novel antiretroviral drug targets?

D. Harrich, Ann Apolloni, N. McMillan, 2006, Current drug targets.

A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.

D. Harrich, Ann Apolloni, M. Kershaw, 2013, Human gene therapy.